about
Differential regulation of somatostatin receptors 1 and 2 mRNA and protein expression by tamoxifen and estradiol in breast cancer cellsTamoxifen Resistance: Emerging Molecular TargetsRole of Sex Hormones in the Development and Progression of Hepatitis B Virus-Associated Hepatocellular CarcinomaMembrane Interactions of Phytochemicals as Their Molecular Mechanism Applicable to the Discovery of Drug Leads from PlantsRoles for miRNAs in endocrine resistance in breast cancerMechanisms and therapeutic advances in the management of endocrine-resistant breast cancerTamoxifen regulation of sphingolipid metabolism--Therapeutic implicationsCytoplasmic PELP1 and ERRgamma protect human mammary epithelial cells from Tam-induced cell deathSoy promotes juvenile granulosa cell tumor development in mice and in the human granulosa cell tumor-derived COV434 cell line.Interaction of tamoxifen and noise-induced damage to the cochlea.Impact of germline BRCA1 mutations and overexpression of p53 on prognosis and response to treatment following breast carcinoma: 10-year follow up data.Laser microdissection and microarray analysis of breast tumors reveal ER-alpha related genes and pathways.New steroidal aromatase inhibitors: suppression of estrogen-dependent breast cancer cell proliferation and induction of cell death.Split-CreERT2: temporal control of DNA recombination mediated by split-Cre protein fragment complementation.miR-17/20 sensitization of breast cancer cells to chemotherapy-induced apoptosis requires Akt1.Cell cycle and anti-estrogen effects synergize to regulate cell proliferation and ER target gene expression.Tamoxifen inhibits malignant peripheral nerve sheath tumor growth in an estrogen receptor-independent mannerAntiestrogenic activity of flavonoid phytochemicals mediated via the c-Jun N-terminal protein kinase pathway. Cell-type specific regulation of estrogen receptor alpha.Molecular mechanisms of tamoxifen therapy for cholangiocarcinoma: role of calmodulin.Application of the McMurry coupling reaction in the synthesis of tri- and tetra-arylethylene analogues as potential cancer chemotherapeutic agentsEstrogen receptor-alpha 36 mediates mitogenic antiestrogen signaling in ER-negative breast cancer cells.Tamoxifen enhances the cytotoxic effects of nelfinavir in breast cancer cells.Synergistic epigenetic reactivation of estrogen receptor-α (ERα) by combined green tea polyphenol and histone deacetylase inhibitor in ERα-negative breast cancer cellsFas binding to calmodulin regulates apoptosis in osteoclasts.Oncogenic HER2{Delta}16 suppresses miR-15a/16 and deregulates BCL-2 to promote endocrine resistance of breast tumors.Synergistic anticancer effects of a bioactive subfraction of Strobilanthes crispus and tamoxifen on MCF-7 and MDA-MB-231 human breast cancer cell lines.Roles of prohibitin in growth control and tumor suppression in human cancersFunctional estrogen receptors in the mitochondria of breast cancer cellsTamoxifen increases nuclear respiratory factor 1 transcription by activating estrogen receptor beta and AP-1 recruitment to adjacent promoter binding sitesTargeted apoptotic effects of thymoquinone and tamoxifen on XIAP mediated Akt regulation in breast cancerTamoxifen ameliorates peritoneal membrane damage by blocking mesothelial to mesenchymal transition in peritoneal dialysis.Equol enhances tamoxifen's anti-tumor activity by induction of caspase-mediated apoptosis in MCF-7 breast cancer cells.Diffusion weighted imaging evaluated the early therapy effect of tamoxifen in an MNU-induced mammary cancer rat modelAn anticancer agent icaritin induces sustained activation of the extracellular signal-regulated kinase (ERK) pathway and inhibits growth of breast cancer cellsExpression of sulfotransferase isoform 1A1 (SULT1A1) in breast cancer cells significantly increases 4-hydroxytamoxifen-induced apoptosisTamoxifen enhances the anticancer effect of cantharidin and norcantharidin in pancreatic cancer cell lines through inhibition of the protein kinase C signaling pathway.The influence of tamoxifen on normal mouse mammary gland homeostasisDiscovery of synthetic Leishmania inhibitors by screening of a 2-arylbenzothiophene library.P-glycoprotein antagonists confer synergistic sensitivity to short-chain ceramide in human multidrug-resistant cancer cells.Dependence receptors: what is the mechanism?
P2860
Q24812181-DF3E359A-DB8C-4062-81A1-24E4FF6E91DBQ26739969-24855B40-C69C-4A67-AD54-30BFFE48F8D0Q26778413-AE98E5EC-1724-4BC6-B7B8-2FBD16E647FAQ26779022-74D11568-472B-45F2-9BD2-E0926451CEF4Q26783076-A0EC1C6E-6EE0-4A3B-9038-91D579957818Q27001260-10AD776B-1832-4C84-9845-0B797B39D477Q28084270-E6B6246E-AA89-4EE0-BE65-FC53B01D979CQ28259195-E642ED66-98CA-46FD-8196-6902EFE1BBAFQ30370581-0E7ADDD0-5880-44D4-9148-CBDBAC6141B4Q30460271-109D7BE2-F827-476E-B6BA-1795F0623590Q30764147-613610F1-AE52-4241-91C4-F5B128A164C0Q33226334-38D4AAB3-94AD-4B7D-937E-BB0121D1A4B5Q33354763-45B30096-4958-4347-910D-1051012172CEQ33519046-BC9F4426-AE3D-4878-AD73-630936CDCD15Q33572268-6713C6C3-0A31-4F8D-838B-BFD95005FB81Q33603027-02F22071-C34C-428F-88FB-D87D1A3D2111Q33746249-2F89300A-F05D-4500-BE03-D3E69E246CF5Q33852622-B8B416E1-8708-4EFE-A76A-DB782C406A33Q34000409-4D53FD98-4764-4519-B0DA-C111AB90FB8CQ34109712-26DA4255-569F-4CDE-8787-032BDD4E8698Q34140383-0F8A09A4-6B38-4C3F-A3C3-E04481197141Q34173405-3B14BF4D-6AD0-42CE-81BF-19E5FD09C82AQ34258435-6C977BFA-A3E0-4ABD-846E-BABC11ED8B68Q34312838-0101FCEA-F7F7-41B1-9353-275BDC3B2C51Q34363866-0A1DE452-6D3A-4CF0-95FE-75FA25F58798Q34468514-46D0CC57-0573-46EC-BA61-83A9F5DF14DEQ34497715-A889571C-1BD6-4121-85DB-010B80F355B4Q34559531-33BB1726-2DBB-4109-A52E-27417BFC9359Q34682354-72FBE8BC-99EA-4811-94E1-DEC8AB356630Q34684291-A1782B57-B33A-49A5-A8B8-52645ECD89CDQ34700117-8D91A800-542F-46EC-A211-7A1434888E53Q34723570-502C3557-D5E1-424D-91C4-CCB8FBD2A86AQ34735514-9F313E10-7EEB-4896-8C77-00015F8B7C87Q34765600-CDD20E4D-330C-4EA4-B64E-6233840AA011Q34793924-5BB77E4A-525A-4BF1-9D79-9E01C3FA48E2Q34993839-A02E11E7-7897-4017-B992-0AE021A5907AQ35000783-2306826E-E7C6-4E16-AFDE-DB256990D1BDQ35015925-6615ACCA-16DC-4F71-B164-BBA1E64EAEDDQ35057879-A8CD9D38-315E-4403-922A-0B67950FB7FEQ35226484-F77E1888-B722-4AB0-92B2-536574DBF8F9
P2860
description
2001 nî lūn-bûn
@nan
2001 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Mechanisms of tamoxifen-induced apoptosis.
@ast
Mechanisms of tamoxifen-induced apoptosis.
@en
Mechanisms of tamoxifen-induced apoptosis.
@nl
type
label
Mechanisms of tamoxifen-induced apoptosis.
@ast
Mechanisms of tamoxifen-induced apoptosis.
@en
Mechanisms of tamoxifen-induced apoptosis.
@nl
prefLabel
Mechanisms of tamoxifen-induced apoptosis.
@ast
Mechanisms of tamoxifen-induced apoptosis.
@en
Mechanisms of tamoxifen-induced apoptosis.
@nl
P356
P1433
P1476
Mechanisms of tamoxifen-induced apoptosis.
@en
P2093
P2888
P304
P356
10.1023/A:1012437607881
P577
2001-12-01T00:00:00Z
P6179
1016525355